{"id":9609,"date":"2023-11-04T15:45:06","date_gmt":"2023-11-04T15:45:06","guid":{"rendered":"https:\/\/infundpros.com\/investment\/biotechs-bounce-new-highs-for-ideaya-olema-and-vertex\/"},"modified":"2023-11-04T15:45:08","modified_gmt":"2023-11-04T15:45:08","slug":"biotechs-bounce-new-highs-for-ideaya-olema-and-vertex","status":"publish","type":"post","link":"https:\/\/infundpros.com\/?p=9609","title":{"rendered":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex."},"content":{"rendered":"
\n

Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right now.<\/p>\n

This sector is the non-value stock sector \u2014 investors going for growth like to place money here when they feel that a bottom may be in place.<\/p>\n

I\u2019m not an expert on the reasons that a single biotech may be better than another, but I do follow price trends and that\u2019s what makes the group interesting.<\/p>\n

The group\u2019s upward blast on Friday came on increased volume, a sign (not a guarantee) that these stocks are of interest again to those gauging that reward may now be worth the risk.<\/p>\n

Biotech Price Charts: An ETF and 3 Stocks:<\/h2>\n

The SPDR S&P Biotech Exchange Traded Fund consists of 135 stocks, trades with a price-earnings ratio of 19 and at about 3 times book value. Considered a benchmark for the sector, here\u2019s the weekly price chart:<\/p>\n

<\/fbs-ad><\/p>\n

You can see how it peaked at $175 in early 2021 and now goes for $71.46, a drop of 58%. The ETF had a decent rally this week but still trades beneath both its 50-day moving average (the blue line) and its 200-day moving average. Note that, so far, it\u2019s managed to stay above the mid 2022 low.<\/p>\n

The daily chart for the SPDR S&P Biotech ETF looks like this:<\/p>\n

Buyers stepped it up this week and the biotech benchmark seems to have bottomed \u2014 perhaps temporarily, at least \u2014 at $64. Note that the ETF continues to trade below its moving averages, even with this significant rally.<\/p>\n

Ideaya Biosciences hit a new 52-week high and then backed off. Here\u2019s the daily price chart:<\/p>\n

The Nasdaq-traded \u201cclinical stage precision medicine oncology\u201d company has a market capitalization of $1.81 billion. Unlike many other biotechs, the stock has traded upward since late April and remains above up trending 50-day and 200-day moving averages.<\/p>\n

Olema Pharmaceuticals is another Nasdaq biotech hitting new highs. The daily price chart is here:<\/p>\n

The company, based in San Francisco, California, focuses on cancer treatments for women. Note that the stock could have been purchased at $3 in April and is now priced at $16.59, an extraordinary gain over just 6 months. It\u2019s moves like this that attract the \u201cgrowth\u201d investor.<\/p>\n

Vertex Pharmaceuticals works on treatments for a number of diseases including sickle cell anemia. The Nasdaq traded biotech has a market cap of $97.10 billion. The daily price chart looks like this:<\/p>\n

After the stock hit new highs this week, sellers took profits up there at the $380 level. Vertex traded at $286 as recently as March, as you can see. It hasn\u2019t traded below that up trending 200-day moving average since that month.<\/p>\n

I am no longer on Twitter \u2014 I\u2019ve moved to Threads.net.<\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t…<\/p>\n","protected":false},"author":1,"featured_media":9610,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":{"0":"post-9609","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investment"},"yoast_head":"\nBiotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros<\/title>\n<meta name=\"description\" content=\"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/infundpros.com\/?p=9609\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros\" \/>\n<meta property=\"og:description\" content=\"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right\" \/>\n<meta property=\"og:url\" content=\"https:\/\/infundpros.com\/?p=9609\" \/>\n<meta property=\"og:site_name\" content=\"inFundPros\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-04T15:45:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-04T15:45:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/11\/1699112707_0x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1350\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Press Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Press Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/infundpros.com\/?p=9609#article\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/?p=9609\"},\"author\":{\"name\":\"Press Room\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\"},\"headline\":\"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex.\",\"datePublished\":\"2023-11-04T15:45:06+00:00\",\"dateModified\":\"2023-11-04T15:45:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/infundpros.com\/?p=9609\"},\"wordCount\":476,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"articleSection\":[\"Investment\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/infundpros.com\/?p=9609#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/infundpros.com\/?p=9609\",\"url\":\"https:\/\/infundpros.com\/?p=9609\",\"name\":\"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros\",\"isPartOf\":{\"@id\":\"https:\/\/infundpros.com\/#website\"},\"datePublished\":\"2023-11-04T15:45:06+00:00\",\"dateModified\":\"2023-11-04T15:45:08+00:00\",\"description\":\"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right\",\"breadcrumb\":{\"@id\":\"https:\/\/infundpros.com\/?p=9609#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/infundpros.com\/?p=9609\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/infundpros.com\/?p=9609#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/infundpros.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/infundpros.com\/#website\",\"url\":\"https:\/\/infundpros.com\/\",\"name\":\"Fintech Advance\",\"description\":\"Latest Finance and Tech News and Updates\",\"publisher\":{\"@id\":\"https:\/\/infundpros.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/infundpros.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/infundpros.com\/#organization\",\"name\":\"Fintech Advance\",\"url\":\"https:\/\/infundpros.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png\",\"width\":409,\"height\":70,\"caption\":\"Fintech Advance\"},\"image\":{\"@id\":\"https:\/\/infundpros.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff\",\"name\":\"Press Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/infundpros.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"contentUrl\":\"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png\",\"caption\":\"Press Room\"},\"sameAs\":[\"https:\/\/infundpros.com\"],\"url\":\"https:\/\/infundpros.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros","description":"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/infundpros.com\/?p=9609","og_locale":"en_US","og_type":"article","og_title":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros","og_description":"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right","og_url":"https:\/\/infundpros.com\/?p=9609","og_site_name":"inFundPros","article_published_time":"2023-11-04T15:45:06+00:00","article_modified_time":"2023-11-04T15:45:08+00:00","og_image":[{"width":1350,"height":900,"url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/11\/1699112707_0x0.jpg","type":"image\/jpeg"}],"author":"Press Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Press Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/infundpros.com\/?p=9609#article","isPartOf":{"@id":"https:\/\/infundpros.com\/?p=9609"},"author":{"name":"Press Room","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff"},"headline":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex.","datePublished":"2023-11-04T15:45:06+00:00","dateModified":"2023-11-04T15:45:08+00:00","mainEntityOfPage":{"@id":"https:\/\/infundpros.com\/?p=9609"},"wordCount":476,"commentCount":0,"publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"articleSection":["Investment"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/infundpros.com\/?p=9609#respond"]}]},{"@type":"WebPage","@id":"https:\/\/infundpros.com\/?p=9609","url":"https:\/\/infundpros.com\/?p=9609","name":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex. | inFundPros","isPartOf":{"@id":"https:\/\/infundpros.com\/#website"},"datePublished":"2023-11-04T15:45:06+00:00","dateModified":"2023-11-04T15:45:08+00:00","description":"Biotechs rallied this week, a strong indication that \u201crisk on\u201d is back on after Fed Chair Jerome Powell said interest rates won\u2019t be raised again right","breadcrumb":{"@id":"https:\/\/infundpros.com\/?p=9609#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/infundpros.com\/?p=9609"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/infundpros.com\/?p=9609#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/infundpros.com\/"},{"@type":"ListItem","position":2,"name":"Biotechs Bounce. New Highs For Ideaya, Olema And Vertex."}]},{"@type":"WebSite","@id":"https:\/\/infundpros.com\/#website","url":"https:\/\/infundpros.com\/","name":"Fintech Advance","description":"Latest Finance and Tech News and Updates","publisher":{"@id":"https:\/\/infundpros.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/infundpros.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/infundpros.com\/#organization","name":"Fintech Advance","url":"https:\/\/infundpros.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/tech-logo.png","width":409,"height":70,"caption":"Fintech Advance"},"image":{"@id":"https:\/\/infundpros.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/infundpros.com\/#\/schema\/person\/87f7e632b195ea95c91503d9281f5eff","name":"Press Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/infundpros.com\/#\/schema\/person\/image\/","url":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","contentUrl":"https:\/\/infundpros.com\/wp-content\/uploads\/2023\/10\/avatar_user_1_1697230663-96x96.png","caption":"Press Room"},"sameAs":["https:\/\/infundpros.com"],"url":"https:\/\/infundpros.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9609"}],"version-history":[{"count":1,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9609\/revisions"}],"predecessor-version":[{"id":9611,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/posts\/9609\/revisions\/9611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=\/wp\/v2\/media\/9610"}],"wp:attachment":[{"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/infundpros.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}